These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 4151923

  • 1. Comparison of tyrosine hydroxylase and dopamine-beta-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity.
    Hollister AS, Breese GR, Cooper BR.
    Psychopharmacologia; 1974 Mar 21; 36(1):1-16. PubMed ID: 4151923
    [No Abstract] [Full Text] [Related]

  • 2. Shock-induced locomotor excitation following acute and chronic amphetamine treatment.
    Kokkinidis L, Irwin J, Anisman H.
    Neuropharmacology; 1979 Jan 21; 18(1):13-22. PubMed ID: 33347
    [No Abstract] [Full Text] [Related]

  • 3. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH, Davis WM.
    J Pharmacol Exp Ther; 1977 Jul 21; 202(1):182-91. PubMed ID: 17725
    [No Abstract] [Full Text] [Related]

  • 4. Ventricular infusion of norepinephrine and amphetamine: direct versus indirect action.
    Segal DS, McAllister C, Geyer MA.
    Pharmacol Biochem Behav; 1974 Jul 21; 2(1):79-86. PubMed ID: 4857225
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of the behavioral depressant effects of biogenic amine depleting and neuroleptic agents following various 6-hydroxydopamine treatments.
    Cooper BR, Grant LD, Breese GR.
    Psychopharmacologia; 1973 Jul 17; 31(2):95-109. PubMed ID: 4722209
    [No Abstract] [Full Text] [Related]

  • 6. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
    Cooper BR, Breese GR, Grant LD, Howard JL.
    J Pharmacol Exp Ther; 1973 May 17; 185(2):358-70. PubMed ID: 4703827
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine.
    Breese GR, Cooper BR, Mueller RA.
    Br J Pharmacol; 1974 Oct 17; 52(2):307-314. PubMed ID: 4155993
    [Abstract] [Full Text] [Related]

  • 9. Relationship of biogenic amines to behavior.
    Breese GR, Cooper BR, Hollister AS.
    J Psychiatr Res; 1974 Oct 17; 11():125-33. PubMed ID: 4282384
    [No Abstract] [Full Text] [Related]

  • 10. Reversal by L-DOPA of the suppression of locomotor activity induced by inhibition of tyrosine-hydroxylase and DA-beta-hydroxylase in mice.
    Ahlenius S.
    Brain Res; 1974 Mar 29; 69(1):57-65. PubMed ID: 4150408
    [No Abstract] [Full Text] [Related]

  • 11. Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine.
    Creese I, Iversen SD.
    Brain Res; 1973 Jun 15; 55(2):369-82. PubMed ID: 4145950
    [No Abstract] [Full Text] [Related]

  • 12. Effects of catecholaminergic drugs upon memory storage processes in mice.
    Haycock JW, Van Buskirk R, McGaugh JL.
    Behav Biol; 1977 Jul 15; 20(3):281-310. PubMed ID: 19010
    [No Abstract] [Full Text] [Related]

  • 13. Dopaminergic nature of amphetamine-induced pecking in pigeons.
    Cheng HC, Bhatnagar RK, Long JP.
    Eur J Pharmacol; 1975 Jul 15; 33(2):319-24. PubMed ID: 1237409
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dopaminergic mediation of the interoceptive cue produced by d-amphetamine in rats.
    Schechter MD, Cook PG.
    Psychopharmacologia; 1975 May 28; 42(2):185-93. PubMed ID: 240181
    [Abstract] [Full Text] [Related]

  • 16. Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate.
    Finn IB, Iuvone PM, Holtzman SG.
    Neuropharmacology; 1990 Jul 28; 29(7):625-31. PubMed ID: 1974712
    [Abstract] [Full Text] [Related]

  • 17. Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat.
    Carter CJ, Pycock CJ.
    Brain Res; 1980 Jun 16; 192(1):163-76. PubMed ID: 7189685
    [Abstract] [Full Text] [Related]

  • 18. Central effects of 6-hydroxydopamine.
    De Carolis AS, Ziegler H, Del Basso P, Longo VG.
    Physiol Behav; 1971 Nov 16; 7(5):705-8. PubMed ID: 5170825
    [No Abstract] [Full Text] [Related]

  • 19. Effects of imipramine, desipramine and monoamine oxidase inhibitors on the metabolism and psychomotor stimulant actions of d-amphetamine in mice.
    Lew C, Iversen SD, Iversen LL.
    Eur J Pharmacol; 1971 May 16; 14(4):351-9. PubMed ID: 4400534
    [No Abstract] [Full Text] [Related]

  • 20. Effect of tyrosine hydroxylase inhibition on the action of 6-hydroxydopamine.
    Jonsson G, Sachs C.
    Res Commun Chem Pathol Pharmacol; 1973 Mar 16; 5(2):287-96. PubMed ID: 4144667
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.